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Epidemiological studies show that, worldwide, the
number of people aged over 65 will increase
substantially in the next decades and that a
considerable proportion of this population will
develop dementia.1 Ample evidence shows that ageing
is associated with a high rate of painful conditions, irre-
spective of cognitive status.2 The number of patients
with dementia who will experience painful conditions
is therefore likely to increase. A key question relates to
whether and how patients with dementia perceive pain.
Patients with dementia may express their pain in ways
that are quite different from those of elderly people
without dementia.3 Particularly in the more severe
stages of dementia, therefore, the complexity and con-
sequent (frequent) inadequacy of pain assessment
leads to the undertreatment of pain.
The most commonly used pain assessment
instruments seem to be selected primarily according to
the communicative capacity of the patient (self report
pain rating scales for communicative patients and
observation scales for non-communicative patients)
instead of according to two main aspects of pain—the
sensory-discriminative and motivational-affective
aspects. In particular, the motivational-affective aspects
of pain are assessed by observation scales, which
should therefore be applied to every patient,
irrespective of ability to communicate. Distinction
between the sensory-discriminative and motivational-
affective aspects of pain is of great clinical relevance, as
the motivational-affective aspects are particularly likely
to reflect pain that needs treatment.4 Moreover, differ-
entiating between these two aspects of pain in relation
to the neuropathology of the various subtypes of
dementia provides insight into the basis of the
alterations in the pain experiences of elderly people
with dementia. Future experimental and clinical
studies should not only focus on subtypes of dementia
but should go a step further and assess pain in
disorders in which pain is already present at a stage
without cognitive impairment and during the course of
which patients become cognitively impaired.
Methods
We selected data for this review from our personal files
and from searches of PubMed. We used the search
terms pain, chronic pain, persistent pain, acute pain,
pain assessment, pain treatment, human, clinical
studies, experimental studies, dementia, Alzheimer’s
disease, vascular dementia, frontotemporal dementia,
Parkinson’s disease, and multiple sclerosis.
Undertreatment of pain in dementia
Several observational studies indicate that pain is
undertreated among cognitively impaired elderly peo-
ple. Fewer analgesics are prescribed for the oldest cat-
egory of cancer patients ( > 75 years) than for younger
patients, and low cognitive performance was one of the
independent predictors of this finding.5 In addition,
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Summary points
Undertreatment of pain in dementia is a frequent
and frightening observation; its risk increases with
the severity of dementia
The development of tools by which pain can be
better recognised in non-communicative patients
with dementia is one of the primary goals of
future research
Experimental and clinical studies should
differentiate more consistently between the
sensory-discriminative and motivational-affective
aspects of pain and among the various subtypes
of dementia
Self report pain rating scales, administered to
communicative patients with dementia, focus on
the intensity of pain; observation scales, until now
reserved for non-communicative patients, also
assess affective aspects of pain
Observation scales should become a permanent
part of pain assessment, irrespective of cognitive
status
Pain assessment should be a regular component
of care in such disorders as Parkinson’s disease
and multiple sclerosis, in which pain is present at
a stage in which cognitive function is relatively
preserved
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people in advanced stages of dementia who have had
hip fractures receive significantly less opioid analgesics
than do those who are cognitively intact.6 Another
remarkable finding is that the prevalence of use of
analgesic is considerably lower among patients with
Alzheimer’s disease than in those with vascular demen-
tia.7 One possible explanation for this finding is that an
impairment in language, which limits patients’ ability
to communicate about their pain, is more common in
Alzheimer’s disease than in vascular dementia.8 These
observations stress the importance of increasing our
knowledge of pain recognition in this population.3
Assessment of the sensory-discriminative
and motivational-affective aspects of pain
In clinical practice, the selection of instruments to
assess pain in dementia is based primarily on whether
the patient is able to communicate verbally about the
pain. For example, self report pain rating scales are
administered to patients who can still communicate
about their pain (table 1). These scales are unidimen-
sional, however, as they generally target only the
sensory-discriminative aspects of pain (that is, presence
and intensity), instead of the important motivational-
affective aspects.2 The reason these scales are used is
that even patients with moderate cognitive impairment
are able to use them easily to report the intensity of
pain.9–11 To assess abstract thinking, some researchers
have added prerequisites for understanding, including
abstract pain scales—such as the visual analogue scales,
the cognitive capacity screening examination, and
drawing a clock—to their protocols.12
Pain assessment in non-communicative patients
relies primarily on observation scales (table 1).3 Such
scales may provide information about the
motivational-affective aspects of pain, as shown by both
physiological signs (for example, frequency of breath-
ing) and physical signs, such as facial expressions (for
example, seeming to be frightened). Facial expressions
can be evaluated by a specific coding system and seem
to be reliable indicators of pain.13 One disadvantage of
typical observation scales is the necessary assumption
that signs that are normally indicative of pain (such as
guarding, bracing, moaning) are also representative of
pain in elderly patients with dementia.14 This
assumption is doubtful, however, given the identifica-
tion of less obvious or atypical behavioural presenta-
tions in some people with dementia.3 For example,
“absence of a relaxed body posture,” one of the items of
the discomfort scale-dementia of Alzheimer type (DS-
DAT), may also be a reflection of the extrapyramidal
symptoms that can occur in Alzheimer’s disease.15 On
the other hand, assessing for pain only with tools that
include typical pain behaviours but do not recognise
subtle behaviours and changes in usual activities may
result in under-recognition of pain in this population.
Additional insight into a patient’s pain experience
could emerge from measuring such autonomic
responses as blood pressure and heart rate, although
evidence indicates that these measures are not particu-
larly sensitive. In an experimental pain study, research-
ers observed that only high intensity pain provoked
similar increases in systolic blood pressure among both
patients with Alzheimer’s disease and elderly people
without dementia. In contrast, low intensity painful
stimulation induced smaller increases in heart rate
among patients with Alzheimer’s disease than in
elderly people without dementia.16 These results
suggest that Alzheimer’s disease involves a higher
threshold for autonomic activation.16 These findings
have two important clinical implications: autonomic
responses in non-communicative patients may indicate
a high level of pain intensity, and low autonomic
responses to pain do not reflect the absence of pain.
Heart rate responses to pain have recently been found
to be negatively correlated with degree of cognitive
impairment and deterioration of electrical activity in
the brain in Alzheimer’s disease, regardless of normal
tactile and pain thresholds.17 These results provide fur-
ther support for the suggestion that patients with
Alzheimer’s disease can still differentiate between
tactile and painful stimuli, even in advanced stages of
the disease and in the presence of blunted autonomic
responses.
Taken together, these data indicate that observation
scales might be useful for assessing the intensity and
motivational-affective aspects of pain in patients with
dementia and that these scales should be administered
to all patients, not only to those who are non-
communicative as is the case in current practice.
Assessing autonomic responses does not seem to be
useful, as these responses do not provide an accurate
reflection of the perceived intensity of pain.
Sensory-discriminative and
motivational-affective aspects of pain in
subtypes of dementia
The processing of sensory-discriminative aspects
occurs in the lateral pain system, whereas
motivational-affective aspects are processed by the
medial pain system.4 Although the distinction between
these aspects of pain, and subsequently between the
two pain systems, has so far received too little
attention in clinical studies on pain in dementia,
experimental pain studies have shown its importance.
Table 1 Pain assessment instruments in communicative and non-communicative
patients
Scale Assessment Aspect of pain
Most frequently used self report pain rating scales for communicative patients*
Verbal rating scales:
Verbal descriptor scale Seven adjectives: no pain to most intense pain Intensity
Verbal rating scale Five labels, such as “distressing” Intensity/affect
Visual rating scales:
Visual analogue scale No pain to most intense pain Intensity
Faces pain scale Seven faces expressing no pain to most intense pain Intensity/affect
Numerical rating scales:
Numeric rating scale 1-10 horizontal line Intensity
21-point box scale 21 boxes: no pain to pain as bad as it could be Intensity
Selected available observation scales for pain assessment in non-communicative patients†
DS-DATw1 Nine indicators (such as frowning) Intensity/affect
CNPIw2 Six indicators (such as grimacing) Intensity/affect
NOPPAINw3 For example, pain words, pain faces, bracing Intensity/affect
PACSLACw4 Four subscales (such as facial expressions) Intensity/affect
Doloplus 2w5 Three subscales: for example, somatic (such as facial)
reactions
Intensity/affect
CNPI=checklist of non-verbal pain indicators; DS-DAT=discomfort scale-dementia of Alzheimer type;
NOPPAIN=non-communicative patient’s pain assessment instrument. PACSLAC=pain assessment checklist
for seniors with limited ability to communicate.
*For comparisons of psychometric properties and more detailed description, see references 9, 11, 12, and w6.
†See www.cityofhope.org/prc/elderly.asp for a recent review of 10 observation scales, including the five
observation scales presented here, that have the strongest psychometric properties.
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Registration of pain related somato-sensory evoked
potentials in patients with severe dementia showed that
the processing of pain that involves areas of the medial
pain system (such as the anterior cingulate gyrus) was
impaired, although the pain stimulus itself was perceived
adequately (lateral pain system).18 Benedetti et al
observed that the pain thresholds (a sensory-
discriminative aspect) of patients with Alzheimer’s
disease did not differ from those of elderly people with-
out dementia, whereas pain tolerance (a motivational-
affective aspect) was significantly increased in the
Alzheimer’s disease group.19
The explanation of these findings is that areas that
belong to the medial pain system (such as the thalamic
intralaminar nuclei) and that play an important role in
the motivational-affective processing of pain are
severely affected in Alzheimer’s disease.20 In contrast,
the primary sensory areas (the lateral pain system) are
relatively preserved in Alzheimer’s disease,21 which
explains the unchanged pain threshold (table 2). The
lateral pain system does show some functional decline,
however, as the sensory threshold was elevated in
patients with Alzheimer’s disease, compared with
elderly people without dementia,22 and patients with
Alzheimer’s disease indicated that the pain they
experienced was less intense.23 In other words,
although patients with Alzheimer’s disease may still
perceive the presence of pain, they may experience its
intensity and affective aspects to a lesser extent. Conse-
quently, people with dementia may have difficulty
understanding the meaning of the sensation and plac-
ing it in context. This could potentially explain the
atypical behavioural responses observed in this
population (such as frowning or fearful expressions,
combativeness, withdrawal, and agitation).
In summary, with respect to Alzheimer’s disease,
the change in the processing of the affective
components of experimental pain (higher tolerance)
resembles the decrease in the motivational-affective
components of clinical pain.23 This is noteworthy, as
experimental studies often use acute pain stimuli (such
as electrical stimuli),19 although most elderly people in
nursing homes have persistent pain.24 Interestingly, the
incidence, severity, and duration of post-lumbar punc-
ture headache (an acute painful condition) were found
to be low in patients with dementia,25 supporting the
role of the medial pain system in processing the initial
motivational-affective aspects of experimental acute
pain.26 Persistent pain is characterised by “secondary”
motivational-affective aspects of pain, however, in
which the cognitive appraisal of the pain (for example,
the future consequences of and behavioural responses
to pain) plays a very important role.27 Instruments that
assess pain in dementia should therefore focus on pain
related cognitive processes as well.
To date, no experimental pain studies have been
conducted in other subtypes of dementia, such as vas-
cular dementia and frontotemporal dementia. A recent
review of the neuropathology of these disorders
indicates that atrophy in the prefrontal cortex in fronto-
temporal dementia and white matter lesions in
vascular dementia, in which areas become discon-
nected (de-afferentiation), could be responsible for the
clinically observed respective decrease and increase in
the motivational-affective aspects of pain (table 2).28
The difference in pain experience between subtypes of
dementia underscores that studies on pain should not
focus solely on the general definitions of “cognitively
impaired elderly people” or “elderly people with
dementia.” A systematic key word search of PubMed,
however, shows that such broad diagnoses were still
used in most pain studies in the past decade
(1994-2004) (figure).
Future
In disorders with a high risk of cognitive impairment,
such as Parkinson’s disease and multiple sclerosis, pain
is a prominent clinical symptom at a stage in which
patients’ cognitive status is relatively preserved.29 30 Pain
syndromes that often occur in these patients include
Table 2 Relation between neuropathology and results of experimental and clinical studies with respect to influence of subtypes of
dementia, and the influence of Parkinson’s disease and multiple sclerosis without cognitive impairment, on motivational-affective
aspects and presence or intensity of pain
Condition
Motivational-affective aspects of pain Presence or intensity of pain
Possible neuropathological
involvement
Experimental and
clinical results
Possible neuropathological
involvement
Experimental and clinical
results
Alzheimer’s disease Degeneration of thalamic
intralaminar nuclei
↓ Relatively unaffected Relatively unaffected
Vascular dementia De-afferentiation ↑ Not examined Not examined
Frontotemporal dementia Degeneration of prefrontal
cortex
↓ Not examined Not examined
Parkinson’s disease, not
cognitively impaired
Degeneration of brain stem
nuclei
↑ Relatively unaffected Not examined
Multiple sclerosis, not
cognitively impaired
De-afferentiation ↑ Dysfunction of spinothalamic
tract
↓
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Number of clinical and experimental publications on pain in
dementia, Alzheimer’s disease, frontotemporal dementia, and vascular
dementia between 1994 and 2004. Note that most of the papers do
not distinguish the subtype of dementia
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trigeminal neuralgia, pain related to spasticity and
rigidity, radicular-neuropathic disorders, and central
pain.29 30 To date, the relation between the site of the
neuropathology (such as cortical atrophy or white
matter lesions) and pain experience has received little
attention in these disorders. Depending on the location
of the neuropathology, degeneration of the various
brain stem areas (such as the locus coeruleus) that are
normally involved in the inhibition of nociceptive
stimuli at the spinal dorsal horn could hypothetically
explain the clinically observed increase in the
motivational-affective aspects of pain in Parkinson’s
disease.31 The sensory-discriminative aspects have yet
to be clinically examined in Parkinson’s disease (table
2). As in vascular dementia, de-afferentiation by white
matter lesions may explain the increase in affective-
emotional pain in multiple sclerosis. Furthermore,
reductions have been observed in pain-temperature
sensation (a sensory-discriminative aspect), possibly as
a result of a dysfunction of the spinothalamic tract
(table 2).32
Because some of these patients inevitably develop
cognitive impairments during the course of their
disease, it is alarming to realise that the experience of
pain and all of its aspects during this stage remain to be
examined. This lack of knowledge hampers the
development of effective pain treatment strategies with
respect to not only the painful conditions in the cogni-
tively impaired stage but also the side effects of drugs
in Parkinson’s disease and multiple sclerosis. For
example, in Parkinson’s disease, levodopa can provoke
pain and burning paraesthesia,33 and an increase in
pain has been observed when using interferon beta in
multiple sclerosis.29 The extent to which these side
effects are influenced by alterations in cognitive
impairment is unknown. These examples illustrate that
people who care for elderly patients should be alert to
pain at all stages of neurodegenerative disorders,
irrespective of a patient’s cognitive status.
In the coming decade, this line of research should
progress, particularly if researchers differentiate among
the various aspects of pain and pay attention to the vari-
ous subtypes of dementia and the stage of the neurode-
generative disorder. The role of pain in diseases that can
cause cognitive impairment, such as Parkinson’s disease
and multiple sclerosis, must be incorporated into future
experimental and clinical pain studies.
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Endpiece
The ideal diagnosis
One finger in the throat and one in the rectum
makes a good diagnostician.
Sir William Osler (1849-1919), Canadian born
British physician and educator
Fred Charatan, retired geriatric physician, Florida
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